Published in Cryst Growth Des on August 26, 2016
Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few? Cryst Growth Des (2017) 0.75
The Cambridge Structural Database. Acta Crystallogr B Struct Sci Cryst Eng Mater (2016) 34.37
Crystalline solids. Adv Drug Deliv Rev (2001) 1.96
Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev (2001) 1.29
Solid form screening--a review. Eur J Pharm Biopharm (2008) 1.23
Thermodynamics of hydrogen bonding in hydrophilic and hydrophobic media. J Phys Chem B (2006) 1.23
A probabilistic approach to space-group determination from powder diffraction data. Acta Crystallogr A (2001) 1.21
High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv Drug Deliv Rev (2004) 1.17
Complex Polymorphic System of Gallic Acid-Five Monohydrates, Three Anhydrates, and over 20 Solvates. Cryst Growth Des (2012) 1.15
Formation of isomorphic desolvates: creating a molecular vacuum. J Pharm Sci (1998) 1.12
Structure and energetics of the hydronium hydration shells. J Phys Chem A (2007) 1.10
Structural relationship and desolvation behavior of cromolyn, cefazolin and fenoprofen sodium hydrates. Int J Pharm (2000) 1.09
The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism. J Ethnopharmacol (2006) 1.09
The complexity of hydration of phloroglucinol: a comprehensive structural and thermodynamic characterization. J Phys Chem B (2012) 1.04
Estimating the hydrogen bond energy. J Phys Chem A (2010) 1.03
Facts and fictions about polymorphism. Chem Soc Rev (2015) 1.00
Anti-proliferative and cytotoxic effects of Strychnos nux-vomica root extract on human multiple myeloma cell line - RPMI 8226. Food Chem Toxicol (2008) 0.95
Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line. Life Sci (2011) 0.94
Development of a targeted polymorph screening approach for a complex polymorphic and highly solvating API. J Pharm Sci (2010) 0.93
Insights into hydrate formation and stability of morphinanes from a combination of experimental and computational approaches. Mol Pharm (2014) 0.91
Alternate interpretation of the role of water in the erythromycin structure. J Pharm Sci (1985) 0.90
Exploring the solid-form landscape of pharmaceutical hydrates: transformation pathways of the sodium naproxen anhydrate-hydrate system. Pharm Res (2012) 0.89
Creatine: Polymorphs Predicted and Found. Cryst Growth Des (2014) 0.88
Navigating the Waters of Unconventional Crystalline Hydrates. Mol Pharm (2015) 0.87
Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets. J Pharm Sci (2007) 0.85
Identification and characterization of stoichiometric and nonstoichiometric hydrate forms of paroxetine HCl: reversible changes in crystal dimensions as a function of water absorption. Mol Pharm (2012) 0.84
The crystalline state of methylene blue: a zoo of hydrates. Phys Chem Chem Phys (2012) 0.84
Dehydration kinetics of piroxicam monohydrate and relationship to lattice energy and structure. J Pharm Sci (2004) 0.84
Pseudopolymorphism in brucine: brucine-water (1/2), the third crystal hydrate of brucine. Acta Crystallogr C (2007) 0.83
Novel identification of pseudopolymorphic changes of theophylline during wet granulation using near infrared spectroscopy. J Pharm Sci (2001) 0.83
Influence of processing-induced phase transformations on the dissolution of theophylline tablets. AAPS PharmSciTech (2004) 0.82
Towards effective solid form screening. J Pharm Sci (2010) 0.81
Analgesic and anti-inflammatory activity and pharmacokinetics of alkaloids from seeds of Strychnos nux-vomica after transdermal administration: effect of changes in alkaloid composition. J Ethnopharmacol (2011) 0.81
The cytotoxicity induced by brucine from the seed of Strychnos nux-vomica proceeds via apoptosis and is mediated by cyclooxygenase 2 and caspase 3 in SMMC 7221 cells. Food Chem Toxicol (2007) 0.81
Water diffusion in hydrated crystalline and amorphous sugars monitored using H/D exchange. J Pharm Sci (2002) 0.80
Brucine and two solvates. Acta Crystallogr C (2004) 0.79
Physical characterization of nedocromil sodium hydrates. J Pharm Sci (1998) 0.78
Two pseudopolymorphic hydrates of brucine: brucine-water (1/4) and brucine-water (1/5.25) at 130 K. Acta Crystallogr C (2006) 0.78
Exploring the formation of multiple layer hydrates for a complex pharmaceutical compound. J Phys Chem B (2009) 0.78
[Hygroscopicity of cephalexin crystals]. Yakugaku Zasshi (1982) 0.77
Determination of hydrate transition temperature using transformation kinetics obtained by Raman spectroscopy. J Pharm Biomed Anal (2008) 0.77
Phase transformation in thiamine hydrochloride tablets: Influence on tablet microstructure, physical properties, and performance. J Pharm Sci (2011) 0.76
4-Aminoquinaldine monohydrate polymorphism: Prediction and impurity aided discovery of a difficult to access stable form. CrystEngComm (2015) 0.76
Origins of the unusual hygroscopicity observed in LY297802 tartrate. J Pharm Sci (1998) 0.76
Identification of phase boundaries in anhydrate/hydrate systems. J Pharm Sci (2007) 0.76
Creatine: Polymorphs Predicted and Found. Cryst Growth Des (2014) 0.88
Two polymorphs of 5-cyclohexyl-5-ethylbarbituric acid and their packing relationships with other barbiturates. Acta Crystallogr C Struct Chem (2015) 0.85
Solid state forms of 4-aminoquinaldine - From void structures with and without solvent inclusion to close packing. CrystEngComm (2015) 0.80
Specific energy contributions from competing hydrogen-bonded structures in six polymorphs of phenobarbital. Chem Cent J (2016) 0.79
Crystal structure of the α-racemate of methohexital. Acta Crystallogr E Crystallogr Commun (2015) 0.78
Computational and Experimental Characterization of Five Crystal Forms of Thymine: Packing Polymorphism, Polytypism/Disorder and Stoichiometric 0.8-Hydrate. Cryst Growth Des (2016) 0.77
4-Aminoquinaldine monohydrate polymorphism: Prediction and impurity aided discovery of a difficult to access stable form. CrystEngComm (2015) 0.76
The Hydrogen Bonded Structures of Two 5-Bromobarbituric Acids and Analysis of Unequal C5-X and C5-X' Bond Lengths (X = X' = F, Cl, Br or Me) in 5,5-Disubstituted Barbituric Acids. Crystals (Basel) (2016) 0.75
Why do Hydrates (Solvates) Form in Small Neutral Organic Molecules? Exploring the Crystal Form Landscapes of the Alkaloids Brucine and Strychnine. Cryst Growth Des (2016) 0.75
Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few? Cryst Growth Des (2017) 0.75